Fast Tech, Slow Law? Keeping Up with AI in Medical Devices
Artificial intelligence is transforming medical technology at a rapid pace, creating new opportunities as well as new regulatory challenges. As the FDA marks 50 years of medical device regulation, questions remain about how existing frameworks apply to AI-enabled products and whether regulation can keep pace with innovation.
Please join Stinson LLP for a discussion of the FDA's evolving approach to regulating artificial intelligence in medical devices and gain insight into the key considerations shaping the future of health care innovation.
CLE credit is pending in the following states: AZ, CA, CO, FL, KS, MN, MO, NE, NY & TX.
Please register online to attend this event.
Contact
Related Capabilities
Event Contact
Theresa Gaul
Events Specialist
816.691.3209
theresa.gaul@stinson.com
News & Insights
